Items per page
Sort by

Send to:

Choose Destination

Results: 18

Cited In for PubMed (Select 8263158)


GH and the cardiovascular system: an update on a topic at heart.

Isgaard J, Arcopinto M, Karason K, Cittadini A.

Endocrine. 2015 Feb;48(1):25-35. doi: 10.1007/s12020-014-0327-6. Epub 2014 Jun 28.


Efficacy and safety of sustained-release recombinant human growth hormone in Korean adults with growth hormone deficiency.

Kim Y, Hong JW, Chung YS, Kim SW, Cho YW, Kim JH, Kim BJ, Lee EJ.

Yonsei Med J. 2014 Jul;55(4):1042-8. doi: 10.3349/ymj.2014.55.4.1042.


Growth hormone - insulin-like growth factor-I axis and bone mineral density in adults with thalassemia major.

Soliman A, De Sanctis V, Yassin M, Abdelrahman MO.

Indian J Endocrinol Metab. 2014 Jan;18(1):32-8. doi: 10.4103/2230-8210.126525.


Adult growth hormone deficiency - benefits, side effects, and risks of growth hormone replacement.

Reed ML, Merriam GR, Kargi AY.

Front Endocrinol (Lausanne). 2013 Jun 4;4:64. doi: 10.3389/fendo.2013.00064. eCollection 2013.


Alström syndrome: cardiac magnetic resonance findings.

Corbetti F, Razzolini R, Bettini V, Marshall JD, Naggert J, Tona F, Milan G, Maffei P.

Int J Cardiol. 2013 Aug 20;167(4):1257-63. doi: 10.1016/j.ijcard.2012.03.160. Epub 2012 Apr 10.


Anorexia nervosa: a unified neurological perspective.

Hasan TF, Hasan H.

Int J Med Sci. 2011;8(8):679-703. Epub 2011 Oct 22. Review.


Ghrelin and its potential in the treatment of eating/wasting disorders and cachexia.

Müller TD, Perez-Tilve D, Tong J, Pfluger PT, Tschöp MH.

J Cachexia Sarcopenia Muscle. 2010 Dec;1(2):159-167. Epub 2010 Dec 17.


Early-onset growth hormone deficiency results in diastolic dysfunction in adult-life and is prevented by growth hormone supplementation.

Groban L, Lin M, Kassik KA, Ingram RL, Sonntag WE.

Growth Horm IGF Res. 2011 Apr;21(2):81-8. doi: 10.1016/j.ghir.2011.01.003. Epub 2011 Mar 2.


Ghrelin and cardiovascular diseases.

Zhang G, Yin X, Qi Y, Pendyala L, Chen J, Hou D, Tang C.

Curr Cardiol Rev. 2010 Feb;6(1):62-70. doi: 10.2174/157340310790231662.


Growth hormone replacement therapy: transition from adolescence to adulthood.

Geffner ME.

J Clin Res Pediatr Endocrinol. 2009;1(5):205-8. doi: 10.4274/jcrpe.v1i5.205. Epub 2009 Aug 1. Review.


The GH/IGF-1 Axis and Heart Failure.

Castellano G, Affuso F, Conza PD, Fazio S.

Curr Cardiol Rev. 2009 Aug;5(3):203-15. doi: 10.2174/157340309788970306.


OPPORTUNITY: a randomized clinical trial of growth hormone on outcome in hemodialysis patients.

Kopple JD, Cheung AK, Christiansen JS, Djurhuus CB, El Nahas M, Feldt-Rasmussen B, Lange M, Mitch WE, Wanner C, Wiedemann J, Ikizler TA.

Clin J Am Soc Nephrol. 2008 Nov;3(6):1741-51. doi: 10.2215/CJN.02760608.


Growth hormone, insulin-like growth factors, and the skeleton.

Giustina A, Mazziotti G, Canalis E.

Endocr Rev. 2008 Aug;29(5):535-59. doi: 10.1210/er.2007-0036. Epub 2008 Apr 24. Review.


Epithelial sodium channel is a key mediator of growth hormone-induced sodium retention in acromegaly.

Kamenicky P, Viengchareun S, Blanchard A, Meduri G, Zizzari P, Imbert-Teboul M, Doucet A, Chanson P, Lombès M.

Endocrinology. 2008 Jul;149(7):3294-305. doi: 10.1210/en.2008-0143. Epub 2008 Apr 3.


Echocardiographic assessment of subclinical left ventricular eccentric hypertrophy in adult-onset GHD patients by geometric remodeling: an observational case-control study.

de Gregorio C, Curtò L, Recupero A, Grimaldi P, Almoto B, Venturino M, Cento D, Narbone MC, Trimarchi F, Coglitore S, Cannavò S.

BMC Endocr Disord. 2006 Feb 28;6:1.


The potential for growth hormone in the management of heart failure.

Monson JP, Besser GM.

Heart. 1997 Jan;77(1):1-2. No abstract available.


Insulin-like growth factor-1 enhances ventricular hypertrophy and function during the onset of experimental cardiac failure.

Duerr RL, Huang S, Miraliakbar HR, Clark R, Chien KR, Ross J Jr.

J Clin Invest. 1995 Feb;95(2):619-27.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk